MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing.
Brennan CaruthersFebruary 13, 2017
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Forge Therapeutics Raises $15M Series A Financing to Develop First Novel Gram-Negative Antibiotic In Decades.

Brennan CaruthersApril 25, 2017
Next

miRagen Therapeutics Announces Presentation of MRG-106 Clinical Data at American Society of Hematology Annual Meeting.

Brennan CaruthersNovember 3, 2016

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact